5-Methyl-tetrahydrofolate in prevention of recurrent preeclampsia
- 17 March 2015
- journal article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (6) , 916-920
Abstract
To evaluate the efficacy of 5-methyl-tetrahydrofolate (5-MTHF) supplementation in prevention of recurrent preeclampsia. Retrospective cohort of women who received daily oral 5-MTHF 15 mg supplementation as prophylactic treatment since first trimester for recurrent preeclampsia were compared with women who did not. All asymptomatic singleton gestations with prior preeclampsia (in the previous pregnancy) were included. Women with chronic hypertension were excluded. The primary outcome was the incidence of preeclampsia. Three hundred and three singleton gestation met the inclusion criteria: 157 received 5-MTHF, while 146 did not (control group). Women who received 5-MTHF had a significantly lower incidence of recurrent overall preeclampsia (21.7% versus 39.7%; odds ratio (OR) 0.57, 95% confidence interval (CI) 0.25, 0.69), severe preeclampsia (3.2% versus 8.9%; OR 0.44, 95% CI 0.12-0.97) and early-onset preeclampsia (1.9% versus 7.5%; OR 0.34, 95% CI 0.07-0.87) compared to control. The intervention group delivered about 10 d after the control and had higher birth weight. This retrospective study showed that women with prior preeclampsia who received daily oral 5-MTHF 15 mg supplementation had a significantly lower incidence of overall preeclampsia, severe preeclampsia and early-onset preeclampsia. Randomized controlled trials are needed to confirm our findings.Keywords
This publication has 22 references indexed in Scilit:
- Preventive Effects of Folic Acid Supplementation on Adverse Maternal and Fetal OutcomesPLOS ONE, 2014
- Folic Acid Supplementation and Preterm Birth: Results from Observational StudiesBioMed Research International, 2014
- Absence of Association Between Serum Folate and Preeclampsia in Women Exposed to Food FortificationObstetrics & Gynecology, 2013
- Folic Acid Supplementation During Early Pregnancy and the Risk of Gestational Hypertension and PreeclampsiaHypertension, 2013
- Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?Journal of Perinatal Medicine, 2013
- Folic Acid and L-5-MethyltetrahydrofolateClinical Pharmacokinetics, 2010
- Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesExpert Reviews in Molecular Medicine, 2009
- Prediction and Prevention of Recurrent PreeclampsiaObstetrics & Gynecology, 2008
- Prevention of preeclampsia: A big disappointmentAmerican Journal of Obstetrics and Gynecology, 1998
- Low-Dose Aspirin to Prevent Preeclampsia in Women at High RiskNew England Journal of Medicine, 1998